Developments in Fungal Taxonomy

Total Page:16

File Type:pdf, Size:1020Kb

Developments in Fungal Taxonomy CLINICAL MICROBIOLOGY REVIEWS, July 1999, p. 454–500 Vol. 12, No. 3 0893-8512/99/$04.00ϩ0 Copyright © 1999, American Society for Microbiology. All Rights Reserved. Developments in Fungal Taxonomy JOSEP GUARRO,* JOSEPA GENE´, AND ALBERTO M. STCHIGEL Unitat de Microbiologia, Departament de Cie`ncies Me`diques Ba`siques, Facultat de Medicina i Cie`ncies de la Salut, Universitat Rovira i Virgili, 43201 Reus, Spain INTRODUCTION .......................................................................................................................................................454 THE CONCEPT OF SPECIES IN FUNGI .............................................................................................................455 PHYLOGENY AND EVOLUTION...........................................................................................................................455 NOMENCLATURE.....................................................................................................................................................456 CURRENT MYCOLOGICAL TYPING METHODS..............................................................................................457 Morphology..............................................................................................................................................................457 Downloaded from Molecular Techniques ............................................................................................................................................459 Other Techniques....................................................................................................................................................460 Physiological and biochemical techniques ......................................................................................................460 Secondary metabolites........................................................................................................................................460 Ubiquinone systems............................................................................................................................................461 Fatty acid composition .......................................................................................................................................461 Cell wall composition .........................................................................................................................................461 Protein composition............................................................................................................................................461 THE FUNGAL SYSTEM ...........................................................................................................................................461 CLINICALLY RELEVANT FUNGI..........................................................................................................................462 http://cmr.asm.org/ OOMYCOTA AND HYPHOCHYTRIOMYCOTA..................................................................................................462 ZYGOMYCOTA ..........................................................................................................................................................463 ASCOMYCOTA...........................................................................................................................................................463 Basal Ascomycetes ..................................................................................................................................................466 Unitunicate Pyrenomycetes....................................................................................................................................467 Microascales ........................................................................................................................................................468 Ophiostomatales..................................................................................................................................................469 Sordariales...........................................................................................................................................................469 Hypocreales..........................................................................................................................................................469 Bitunicate Pyrenomycetes ......................................................................................................................................473 on August 27, 2020 by guest Dothideales ..........................................................................................................................................................473 (i) Mycosphaerellaceae...................................................................................................................................474 (ii) Herpotrichiellaceae ..................................................................................................................................475 (iii) Dothideaceae............................................................................................................................................476 (iv) Pleosporaceae...........................................................................................................................................476 Plectomycetes...........................................................................................................................................................477 Eurotiales.............................................................................................................................................................477 Onygenales...........................................................................................................................................................479 Budding Yeasts........................................................................................................................................................483 Saccharomycetales ..............................................................................................................................................483 BASIDIOMYCOTA.....................................................................................................................................................484 Tremellales...............................................................................................................................................................484 Schizophyllales ........................................................................................................................................................488 Agaricales.................................................................................................................................................................488 Ustilaginales ............................................................................................................................................................488 DEUTEROMYCETES (MITOSPORIC FUNGI) ...................................................................................................488 GENERAL CONCLUSIONS.....................................................................................................................................489 ACKNOWLEDGMENTS ...........................................................................................................................................489 REFERENCES ............................................................................................................................................................489 INTRODUCTION mainly to impairments in host defence mechanisms as a conse- quence of viral infections, especially the human immunodefi- The last 20 years or so has seen a growing number of fungal ciency virus epidemic, hematological disorders such as different infections coincident with a dramatic increase in the population of types of leukemia, organ transplants, and more intensive and severely immunocompromised patients. These infections are due aggressive medical practices. Many clinical procedures and treat- ments, such as surgery, the use of catheters, injections, radiation, chemotherapy, antibiotics, and steroids, are risk factors for fungal * Corresponding author. Mailing address: Unitat de Microbiologia, Departament de Cie`ncies Me`diquesBa`siques, Facultat de Medicina i infections. However, these procedures are necessary, and so the Cie`ncies de la Salut, Universitat Rovira i Virgili, 43201 Reus, Spain. incidence of fungal infections will increase accordingly. Phone: 34-977759359. Fax: 34-977759322. E-mail: [email protected]. Until only a few years ago, pathogenic fungi were a well- 454 VOL. 12, 1999 DEVELOPMENTS IN FUNGAL TAXONOMY 455 defined group, some of which were limited to geographical application of the biological-species concept to fungi is com- regions and were well known by clinicians. However, the situ- plicated by the difficulties in mating and in assessing its out- ation has changed considerably, and new infectious agents are come (302). Also, whether a cross is considered fertile or continually appearing, around 20 species yearly. These new sterile depends on the frame of reference. In this sense, pub- opportunistic pathogens have increased the base of knowledge lished accounts of crosses between different species are often of medical mycology, and unexpected changes
Recommended publications
  • Pathogenicity Classification of Fungi Status December 2014 (CGM/141218-03)
    Classification of Organisms: Pathogenicity classification of fungi Status December 2014 (CGM/141218-03) COGEM advice CGM/141218-03 Pathogenicity classification of fungi COGEM advice CGM/141218-03 Dutch Regulations Genetically Modified Organisms In the Decree on Genetically Modified Organisms (GMO Decree) and its accompanying more detailed Regulations (GMO Regulations) genetically modified micro-organisms are grouped in four pathogenicity classes, ranging from the lowest pathogenicity Class 1 to the highest Class 4.1 The pathogenicity classifications are used to determine the containment level for working in laboratories with GMOs. A micro-organism of Class 1 should at least comply with one of the following conditions: a) the micro-organism does not belong to a species of which representatives are known to be pathogenic for humans, animals or plants, b) the micro-organism has a long history of safe use under conditions without specific containment measures, c) the micro-organism belongs to a species that includes representatives of class 2, 3 or 4, but the particular strain does not contain genetic material that is responsible for the virulence, d) the micro-organism has been shown to be non-virulent through adequate tests. A micro-organism is grouped in Class 2 when it can cause a disease in humans or animals whereby it is unlikely to spread within the population while an effective prophylaxis, treatment or control strategy exists, as well as an organism that can cause a disease in plants. A micro-organism is grouped in Class 3 when it can cause a serious disease in humans or animals whereby it is likely to spread within the population while an effective prophylaxis, treatment or control strategy exists.
    [Show full text]
  • Monograph on Dematiaceous Fungi
    Monograph On Dematiaceous fungi A guide for description of dematiaceous fungi fungi of medical importance, diseases caused by them, diagnosis and treatment By Mohamed Refai and Heidy Abo El-Yazid Department of Microbiology, Faculty of Veterinary Medicine, Cairo University 2014 1 Preface The first time I saw cultures of dematiaceous fungi was in the laboratory of Prof. Seeliger in Bonn, 1962, when I attended a practical course on moulds for one week. Then I handled myself several cultures of black fungi, as contaminants in Mycology Laboratory of Prof. Rieth, 1963-1964, in Hamburg. When I visited Prof. DE Varies in Baarn, 1963. I was fascinated by the tremendous number of moulds in the Centraalbureau voor Schimmelcultures, Baarn, Netherlands. On the other hand, I was proud, that El-Sheikh Mahgoub, a Colleague from Sundan, wrote an internationally well-known book on mycetoma. I have never seen cases of dematiaceous fungal infections in Egypt, therefore, I was very happy, when I saw the collection of mycetoma cases reported in Egypt by the eminent Egyptian Mycologist, Prof. Dr Mohamed Taha, Zagazig University. To all these prominent mycologists I dedicate this monograph. Prof. Dr. Mohamed Refai, 1.5.2014 Heinz Seeliger Heinz Rieth Gerard de Vries, El-Sheikh Mahgoub Mohamed Taha 2 Contents 1. Introduction 4 2. 30. The genus Rhinocladiella 83 2. Description of dematiaceous 6 2. 31. The genus Scedosporium 86 fungi 2. 1. The genus Alternaria 6 2. 32. The genus Scytalidium 89 2.2. The genus Aurobasidium 11 2.33. The genus Stachybotrys 91 2.3. The genus Bipolaris 16 2.
    [Show full text]
  • Fungal Allergy and Pathogenicity 20130415 112934.Pdf
    Fungal Allergy and Pathogenicity Chemical Immunology Vol. 81 Series Editors Luciano Adorini, Milan Ken-ichi Arai, Tokyo Claudia Berek, Berlin Anne-Marie Schmitt-Verhulst, Marseille Basel · Freiburg · Paris · London · New York · New Delhi · Bangkok · Singapore · Tokyo · Sydney Fungal Allergy and Pathogenicity Volume Editors Michael Breitenbach, Salzburg Reto Crameri, Davos Samuel B. Lehrer, New Orleans, La. 48 figures, 11 in color and 22 tables, 2002 Basel · Freiburg · Paris · London · New York · New Delhi · Bangkok · Singapore · Tokyo · Sydney Chemical Immunology Formerly published as ‘Progress in Allergy’ (Founded 1939) Edited by Paul Kallos 1939–1988, Byron H. Waksman 1962–2002 Michael Breitenbach Professor, Department of Genetics and General Biology, University of Salzburg, Salzburg Reto Crameri Professor, Swiss Institute of Allergy and Asthma Research (SIAF), Davos Samuel B. Lehrer Professor, Clinical Immunology and Allergy, Tulane University School of Medicine, New Orleans, LA Bibliographic Indices. This publication is listed in bibliographic services, including Current Contents® and Index Medicus. Drug Dosage. The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means electronic or mechanical, including photocopying, recording, microcopy- ing, or by any information storage and retrieval system, without permission in writing from the publisher.
    [Show full text]
  • 1 §4-71A-24 LIST of NONRESTRICTED MICROORGANISMS October 25, 2001 SCIENTIFIC NAME FUNGI Absidia Coerulea Absidia Corymbifera Ab
    §4-71A-24 LIST OF NONRESTRICTED MICROORGANISMS October 25, 2001 SCIENTIFIC NAME FUNGI Absidia coerulea Absidia corymbifera Absidia ramosa Absidia spinosa Acremonium falciforme Acremonium kiliense Acremonium recifei Acremonium vitis Agaricus bitorquis Agaricus bisporus Agaricus campestris Agaricus sp. (Portabello mushroom) Alternaria alternata Alternaria geophilia Apiotrichum humicola Arthrobotrys - all species in genus Aspergillus candidus Aspergillus clavatus Aspergillus cremeus Aspergillus flavipipes Aspergillus flavus Aspergillus fumigatus Aspergillus glaucus Aspergillus nidulans Aspergillus niger Aspergillus ochraceus Aspergillus restrictus Aspergillus terreus Aspergillus ustus Aspergillus versicolor Aspergillus wentii Asteromyces cruciatus Aureobasidium pullulans Auricularia polytricha Bipolaris hawaiiensis Blastomyces dermatitidis Blastoschizomyces capitatus Boletus californicus Boletus granulatus Boletus luteus 1 Nonrestricted Microorganisms §4-71A-24 SCIENTIFIC NAME Boletus variegatus Byssochlamys fulva Candida albicans Candida famata Candida geochares Candida glabrata Candida humicola Candida kefyr Candida krusei Candida lipolytica Candida lusitaniae Candida parapsilosis Candida pseudotropicalis Candida quilliermondii Candida rugosa Candida stellatoidea Candida tropicalis Candida zeylanoides Candelabrella - all species in genus Chaetomium globosum Chrysosporium keratinophilum Chrysosporium liquorum Chrysosporium pruinosum Cladosporium bantianum Cladosporium carrionii Cladosporium trichoides Collybia velutipes Cryptococcus albidus
    [Show full text]
  • Chromoblastomycosis Patricia Chang1, Elba Arana2, Roberto Arenas3
    2XU'HUPDWRORJ\2QOLQH Case Report Chromoblastomycosis Patricia Chang1, Elba Arana2, Roberto Arenas3 1Department of Dermatology, Hospital General de Enfermedades IGSS and Hospital Ángeles, Guatemala, 2Elective student, Hospital General de Enfermedades IGSS and Hospital Ángeles, Guatemala, 3Mycology section, “Dr. Manuel Gea González” Hospital, Mexico City, Mexico Corresponding author: Dr. Patricia Chang, E-mail: [email protected] ABSTRACT Chromoblastomycosis is a subcutaneous, chronic, granulomatous mycosis that occurs more frequently in tropical and subtropical countries. We report a case of chromoblastomycosis of the earlobe due to Fonsecaea sp in a male patient of 34 years old, due to its uncommon localization. Key words: Chromoblastomycosis; Fonsecaea pedrosoi; Fonsecaea compacta; Cladosporium carrionii; Fumagoid cells INTRODUCTION plate, hematic crusts and one retroauricular nodule with slightly warty appearance (Figs. 1 and 2). The rest of the The chromoblastomycosis is a sub cutaneous mycosis physical exam was within normal limits. in tropical and subtropical areas considered as an American disease, the main agents are Fonsecaea The patient says that his disease started 3 years ago pedrosoi, in endemic areas of tropical and subtropical with a small asymptomatic “pimple” in his right ear environments; Fonsecaea compacta, Cladosporium that slowly increased its size until he decided to consult. carrionii. The diagnosis of the disease is through the In the last 6 months he had an occasional itch and presence of fumagoids cells. was prescribed different antibiotics and non-specific creams. He does not remember bruising the area. In our environment, chromoblastomycosis is the third most common subcutaneous mycosis. It predominates Three clinical diagnosis were made based on the in the lower limbs in warty form and F pedrosoi is the clinical data: chromoblastomycosis; leishmaniasis; most frequent etiological agent.
    [Show full text]
  • Ep 3323422 A1
    (19) TZZ¥¥ ¥ _T (11) EP 3 323 422 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 23.05.2018 Bulletin 2018/21 A61K 38/00 (2006.01) C07K 7/08 (2006.01) (21) Application number: 16306539.4 (22) Date of filing: 22.11.2016 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • MARBAN, Céline GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO 68000 COLMAR (FR) PL PT RO RS SE SI SK SM TR • METZ-BOUTIGUE, Marie-Hélène Designated Extension States: 67000 STRASBOURG (FR) BA ME • LAVALLE, Philippe Designated Validation States: 67370 WINTZENHEIM KOCHERSBERG (FR) MA MD • SCHAAF, Pierre 67120 MOLSHEIM (FR) (71) Applicants: • HAIKEL, Youssef • Université de Strasbourg 67000 STRASBOURG (FR) 67000 Strasbourg (FR) • Institut National de la Santé et de la Recherche (74) Representative: Cabinet Becker et Associés Médicale 25, rue Louis le Grand 75013 Paris (FR) 75002 Paris (FR) (54) NEW D-CONFIGURED CATESLYTIN PEPTIDE (57) The present invention relates to a cateslytin pep- no acids residues of said cateslytin are D-configured. The tide having an amino acid sequence consisting or con- invention also relates to the use of said cateslytin peptide sisting essentially in the sequence of SEQ ID NO: 1, as a drug, especially in the treatment of an infection in a wherein at least 80%, preferably at least 90%, of the ami- patient in needs thereof. EP 3 323 422 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 323 422 A1 Description Field of the Invention 5 [0001] The present invention relates to the field of medicine, in particular of infections.
    [Show full text]
  • Phylogeny of the Quambalariaceae Fam. Nov., Including Important Eucalyptus Pathogens in South Africa and Australia
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE STUDIES IN MYCOLOGY 55: 289–298. 2006. provided by Elsevier - Publisher Connector Phylogeny of the Quambalariaceae fam. nov., including important Eucalyptus pathogens in South Africa and Australia Z. Wilhelm de Beer1*, Dominik Begerow2, Robert Bauer2, Geoff S. Pegg3, Pedro W. Crous4 and Michael J. Wingfield1 1Department of Microbiology and Plant Pathology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, 0002, South Africa; 2Lehrstuhl Spezielle Botanik und Mykologie, Institut für Biologie I, Universität Tübingen, Auf der Morgenstelle 1, D-72076 Tübingen, Germany; 3Department of Primary Industries and Fisheries, Horticulture and Forestry Science, Indooroopilly, Brisbane 4068; 4Centraalbureau voor Schimmelcultures, Fungal Biodiversity Centre, P.O. Box 85167, 3508 AD, Utrecht, The Netherlands *Correspondence: Wilhelm de Beer, [email protected] Abstract: The genus Quambalaria consists of plant-pathogenic fungi causing disease on leaves and shoots of species of Eucalyptus and its close relative, Corymbia. The phylogenetic relationship of Quambalaria spp., previously classified in genera such as Sporothrix and Ramularia, has never been addressed. It has, however, been suggested that they belong to the basidiomycete orders Exobasidiales or Ustilaginales. The aim of this study was thus to consider the ordinal relationships of Q. eucalypti and Q. pitereka using ribosomal LSU sequences. Sequence data from the ITS nrDNA were used to determine the phylogenetic relationship of the two Quambalaria species together with Fugomyces (= Cerinosterus) cyanescens. In addition to sequence data, the ultrastructure of the septal pores of the species in question was compared. From the LSU sequence data it was concluded that Quambalaria spp.
    [Show full text]
  • Utilization of the Internal Transcribed Spacer Regions As Molecular Targets
    Medical Mycology 2002, 40, 87±109 Accepted 9July 2001 Review article Utilizationof the internaltranscribed spacer regions as molecular targets to detect andidentify human fungal pathogens P.C.IWEN*, S.H.HINRICHS* & M.E.RUPP Downloaded from https://academic.oup.com/mmy/article/40/1/87/961355 by guest on 29 September 2021 y *Department ofPathology and Microbiology,University ofNebraska MedicalCenter, Omaha, Nebraska, USA; Internal Medicine, y University ofNebraska MedicalCenter, Omaha, Nebraska, USA Advancesin molecular technology show greatpotential for the rapiddetection and identication of fungifor medical,scienti c andcommercial purposes. Numerous targetswithin the fungalgenome have been evaluated, with much of the current work usingsequence areas within the ribosomalDNA (rDNA) gene complex. This sectionof the genomeincludes the 18S,5 8Sand28S genes which codefor ribosomal ¢ RNA(rRNA) andwhich havea relativelyconserved nucleotide sequence among fungi.It alsoincludes the variableDNA sequence areas of the interveninginternal transcribedspacer (ITS) regionscalled ITS1 and ITS2. Although not translatedinto proteins,the ITScoding regions have a criticalrole in the developmentof functional rRNA,with sequencevariations among species showing promiseas signature regionsfor molecularassays. This review of the current literaturewas conducted to evaluateclinical approaches for usingthe fungalITS regions as molecular targets. Multipleapplications using the fungalITS sequences are summarized here including those for cultureidenti cation, phylogenetic
    [Show full text]
  • Notes, Outline and Divergence Times of Basidiomycota
    Fungal Diversity (2019) 99:105–367 https://doi.org/10.1007/s13225-019-00435-4 (0123456789().,-volV)(0123456789().,- volV) Notes, outline and divergence times of Basidiomycota 1,2,3 1,4 3 5 5 Mao-Qiang He • Rui-Lin Zhao • Kevin D. Hyde • Dominik Begerow • Martin Kemler • 6 7 8,9 10 11 Andrey Yurkov • Eric H. C. McKenzie • Olivier Raspe´ • Makoto Kakishima • Santiago Sa´nchez-Ramı´rez • 12 13 14 15 16 Else C. Vellinga • Roy Halling • Viktor Papp • Ivan V. Zmitrovich • Bart Buyck • 8,9 3 17 18 1 Damien Ertz • Nalin N. Wijayawardene • Bao-Kai Cui • Nathan Schoutteten • Xin-Zhan Liu • 19 1 1,3 1 1 1 Tai-Hui Li • Yi-Jian Yao • Xin-Yu Zhu • An-Qi Liu • Guo-Jie Li • Ming-Zhe Zhang • 1 1 20 21,22 23 Zhi-Lin Ling • Bin Cao • Vladimı´r Antonı´n • Teun Boekhout • Bianca Denise Barbosa da Silva • 18 24 25 26 27 Eske De Crop • Cony Decock • Ba´lint Dima • Arun Kumar Dutta • Jack W. Fell • 28 29 30 31 Jo´ zsef Geml • Masoomeh Ghobad-Nejhad • Admir J. Giachini • Tatiana B. Gibertoni • 32 33,34 17 35 Sergio P. Gorjo´ n • Danny Haelewaters • Shuang-Hui He • Brendan P. Hodkinson • 36 37 38 39 40,41 Egon Horak • Tamotsu Hoshino • Alfredo Justo • Young Woon Lim • Nelson Menolli Jr. • 42 43,44 45 46 47 Armin Mesˇic´ • Jean-Marc Moncalvo • Gregory M. Mueller • La´szlo´ G. Nagy • R. Henrik Nilsson • 48 48 49 2 Machiel Noordeloos • Jorinde Nuytinck • Takamichi Orihara • Cheewangkoon Ratchadawan • 50,51 52 53 Mario Rajchenberg • Alexandre G.
    [Show full text]
  • Chromoblastomycosis
    Chromoblastomycosis Also known as … Chromomycosis, Cladosporiosis, Verrucous dermatitis, Fonseca’s disease, Pedroso’s disease What is Chromoblastomycosis? Chromoblastomycosis is a long-term or chronic fungal infection of the skin and tissue underneath the superficial layer of the skin (called the subcutaneous tissue). It is more common in rural, tropical and subtropical areas of the world; it tends to present more severely in those with a suppressed or compromised immune system. What causes Chromoblastomycosis? The fungi that cause chromoblastomycosis tend to be found on wood/bark and in the soil. These tend to enter the skin through a penetrating injury (a splinter, nail, or similar mechanism) especially in farmers, miners & rural area workers There are six fungi that are responsible for the vast majority of cases: Fonsecaea pedrosoi, Fonsecaea compacta, Fonsecaea monophora, Phialophora verrucosa, Cladophialophora carrionii (formerly Cladosporium carrionii), and Rhinocladiella aquaspersa. What does Chromoblastomycosis look like? Chromoblastomycosis is characterised by slow growing, scaly, cauliflower-like (verrucous) lumps. Lesions may clear at the centre forming a ring-like area with a raised border. Surrounding smaller lesions (Satellites) may develop around the site from scratching. The lesions can appear anywhere on the body, but the most affected areas are the feet, legs & arms. What other problems can occur with chromoblastomycosis? The lesions may become secondarily infected with bacteria. The appearance of the lesions associated with chromoblastomycosis can be quite distressing. Very rarely, the long-term or chronic lesions develop a type of skin cancer within, called squamous cell carcinomas (SCCs). How is chromoblastomycosis diagnosed? The diagnosis is usually made after taking a sample from the lesions for fungal scraping, a skin biopsy or tissue culture.
    [Show full text]
  • SIM55 6Jul06.Indd
    STUDIES IN MYCOLOGY 55: 289–298. 2006. Phylogeny of the Quambalariaceae fam. nov., including important Eucalyptus pathogens in South Africa and Australia Z. Wilhelm de Beer1*, Dominik Begerow2, Robert Bauer2, Geoff S. Pegg3, Pedro W. Crous4 and Michael J. Wingfield1 1Department of Microbiology and Plant Pathology, Forestry and Agricultural Biotechnology Institute (FABI), University of Pretoria, Pretoria, 0002, South Africa; 2Lehrstuhl Spezielle Botanik und Mykologie, Institut für Biologie I, Universität Tübingen, Auf der Morgenstelle 1, D-72076 Tübingen, Germany; 3Department of Primary Industries and Fisheries, Horticulture and Forestry Science, Indooroopilly, Brisbane 4068; 4Centraalbureau voor Schimmelcultures, Fungal Biodiversity Centre, P.O. Box 85167, 3508 AD, Utrecht, The Netherlands *Correspondence: Wilhelm de Beer, [email protected] Abstract: The genus Quambalaria consists of plant-pathogenic fungi causing disease on leaves and shoots of species of Eucalyptus and its close relative, Corymbia. The phylogenetic relationship of Quambalaria spp., previously classified in genera such as Sporothrix and Ramularia, has never been addressed. It has, however, been suggested that they belong to the basidiomycete orders Exobasidiales or Ustilaginales. The aim of this study was thus to consider the ordinal relationships of Q. eucalypti and Q. pitereka using ribosomal LSU sequences. Sequence data from the ITS nrDNA were used to determine the phylogenetic relationship of the two Quambalaria species together with Fugomyces (= Cerinosterus) cyanescens. In addition to sequence data, the ultrastructure of the septal pores of the species in question was compared. From the LSU sequence data it was concluded that Quambalaria spp. and F. cyanescens form a monophyletic clade in the Microstromatales, an order of the Ustilaginomycetes.
    [Show full text]
  • Polyketides, Toxins and Pigments in Penicillium Marneffei
    Toxins 2015, 7, 4421-4436; doi:10.3390/toxins7114421 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Polyketides, Toxins and Pigments in Penicillium marneffei Emily W. T. Tam 1, Chi-Ching Tsang 1, Susanna K. P. Lau 1,2,3,4,* and Patrick C. Y. Woo 1,2,3,4,* 1 Department of Microbiology, The University of Hong Kong, Pokfulam, Hong Kong; E-Mails: [email protected] (E.W.T.T.); [email protected] (C.-C.T.) 2 State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong 3 Research Centre of Infection and Immunology, The University of Hong Kong, Pokfulam, Hong Kong 4 Carol Yu Centre for Infection, The University of Hong Kong, Pokfulam, Hong Kong * Authors to whom correspondence should be addressed; E-Mails: [email protected] (S.K.P.L.); [email protected] (P.C.Y.W.); Tel.: +852-2255-4892 (S.K.P.L. & P.C.Y.W.); Fax: +852-2855-1241 (S.K.P.L. & P.C.Y.W.). Academic Editor: Jiujiang Yu Received: 18 September 2015 / Accepted: 22 October 2015 / Published: 30 October 2015 Abstract: Penicillium marneffei (synonym: Talaromyces marneffei) is the most important pathogenic thermally dimorphic fungus in China and Southeastern Asia. The HIV/AIDS pandemic, particularly in China and other Southeast Asian countries, has led to the emergence of P. marneffei infection as an important AIDS-defining condition. Recently, we published the genome sequence of P. marneffei. In the P. marneffei genome, 23 polyketide synthase genes and two polyketide synthase-non-ribosomal peptide synthase hybrid genes were identified.
    [Show full text]